HIGHLIGHTS
- who: Susan Khader Ibrahim u200d and collaborators from the were no trials registered in PACTR as of , October , (online supplemental appendix, )Of the nine studies that related to therapeutics, eight were focused on monoclonal antibodies and one at ebolavirus cell entry inhibitors. Only two studies focused on therapeutic development specific to SUDV have published the article: Sudan virus disease outbreak in Uganda: urgent research gaps, in the Journal: (JOURNAL) of 15/Oct/2022
- what: The authors provide an overview of up-u00adto-u00addate information on the SVD outbreak in Uganda and present the results from . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.